Leuven, Belgium – July 26, 2018. Materialise NV (Nasdaq: MTLS) is realizing its largest Stereolithography project yet – a life-size, 3D-printed reconstruction of the first mammoth skeleton that was ever displayed in Western Europe. The 320 bones making up the skeleton were scanned and digitally reconstructed and will still be printed, finished and fitted with a customized frame to hold up the skeleton. From October onwards, the 3D-printed mammoth will be on display in the Belgian city of Lier, the place where the original mammoth was found.
Leuven, Belgium - July 23, 2018 - Materialise NV (“Materialise”) (NASDAQ:MTLS), aleading provider of additive manufacturing and medical software and of sophisticated 3D printing services, announced today the pricing of its registered underwritten public offering of 3.0 million ADSs at a public offering price of US$13.00 per ADS. Each ADS will represent one ordinary share with no nominal value per share.
Ludwigshafen/Germany, Leuven/Belgium – July 19, 2018 – BASF is expanding its cooperation with Materialise, a leading supplier of 3D printing technologies. At the same time, BASF has agreed to invest US$25 million in the Belgian company, which is headquartered in Leuven. The two partners are working together within the framework of an open business model to continuously improve materials and software for various 3D printing technologies and bring them more rapidly to the market. The companies are focusing on applications in the consumer goods sector and in the automotive and aviation industries. The agreement allows for systematic, wider scale testing and further optimization by BASF of its materials on the machines and within the infrastructure of Materialise.
Leuven, Belgium, July 19, 2018 – Materialise NV ("Materialise") (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, announced today that it intends to commence a registered underwritten public offering of 3.0 million ADSs. Each ADS will represent one ordinary share with no nominal value per share. Materialise intends to grant the underwriters a 30-day option to purchase up to an additional 450,000 ADSs. All of the ADSs in the proposed offering are to be sold by Materialise. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.